Invention Grant
- Patent Title: Nucleic acid aptamer-based diagnostic methods with novel techniques for signal enhancement
-
Application No.: US14565759Application Date: 2014-12-10
-
Publication No.: US09772330B2Publication Date: 2017-09-26
- Inventor: Ofer Nussbaum
- Applicant: APTATECK BIO LTD.
- Applicant Address: IL Rehovot
- Assignee: APTATECK BIO LTD.
- Current Assignee: APTATECK BIO LTD.
- Current Assignee Address: IL Rehovot
- Agency: Browdy and Neimark, PLLC
- Main IPC: G01N33/50
- IPC: G01N33/50 ; G01N33/543 ; C12N15/115 ; C12Q1/68 ; C12Q1/70

Abstract:
The present invention concerns methods for the detection f target molecules in a sample including several steps of signal amplification allowing the detection of a very low number of target molecules in the tested sample. The detection assay is based on the use of a universal probe which enables the signal amplification. The specific recognition of the target molecule is achieved by using a specific binding agent, preferably an aptamer. The invention further concerns kits and methods for the diagnosis of pathological conditions.
Public/Granted literature
- US20150160207A1 NUCLEIC ACID APTAMER-BASED DIAGNOSTIC METHODS WITH NOVEL TECHNIQUES FOR SIGNAL ENHANCEMENT Public/Granted day:2015-06-11
Information query
IPC分类: